PetroHunter Energy Corporation
http://www.petrohunter.com
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From PetroHunter Energy Corporation
Novo Nordisk Bets $256m On Mystery Molecule
The Danish group has licensed an unnamed product with an unknown mechanism.
Chinese Oncology Startups Scoop Up VC/PE Deals In December
Oncology-focused Innovo, CytosinLab, Sino-Cell and Sinogen announced closings of early-stage funding rounds worth up to $14m. Meanwhile, Chinese developers of therapies for asthma, autoimmune skin disorders and rare diseases also raised similar new funds.
Novo Nordisk Looks To Bring AI/ML To Cardiometabolic Disease In Valo Health Deal
Deal Snapshot: The Danish drug maker plans to pay up to $2.7bn to Flagship Pioneering-incubated Valo Health for its AI-enabled small molecule discovery and human genetic data platform.
Finance Watch: Vertex Ventures, Chugai Each Raise New $200m VC Funds
Private Company Edition: Vertex Ventures (not Vertex Pharmaceuticals) closed its third fund, with $200m for life science and medical technologies, while Chugai’s $200m corporate VC fund will invest in drug discovery start-ups. Also, K36 closed a $70m series B round and Attovia launched with $60m.
Company Information
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice